Patents by Inventor Angelo FONTANA

Angelo FONTANA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use and preparation of glycolipids as adjuvants in vaccines
    Patent number: 10722574
    Abstract: The present invention relates to beta-glycolipid derivatives, their preparation and use as adjuvants in vaccines, as being suitable for being co-administered with antigens for vaccine prophylaxis and therapy. In certain embodiments, the beta-glycolipid derivatives of the invention also in their salified or complex form, are suitable for being co-administered with antigens for both therapeutic and prophylactic purposes or for vaccine prophylaxis and therapy.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: July 28, 2020
    Assignee: CONSIGLIO NAZIONALE DELLE RICERCHE
    Inventors: Angelo Fontana, Emiliano Manzo, Adele Cutignano, Raffaele De Palma
  • USE AND PREPARATION OF GLYCOLIPIDS AS ADJUVANTS IN VACCINES
    Publication number: 20180344843
    Abstract: The present invention relates to beta-glycolipid derivatives, their preparation and use as adjuvants in vaccines, as being suitable for being co-administered with antigens for vaccine prophylaxis and therapy. In certain embodiments, the beta-glycolipid derivatives of the invention also in their salified or complex form, are suitable for being co-administered with antigens for both therapeutic and prophylactic purposes or for vaccine prophylaxis and therapy.
    Type: Application
    Filed: June 13, 2018
    Publication date: December 6, 2018
    Inventors: Angelo FONTANA, Emiliano MANZO, Adele CUTIGNANO, Raffaele DE PALMA
  • BETA-GLYCOLIPIDS FOR USE AS ADJUVANTS
    Publication number: 20160151483
    Abstract: The present invention relates to beta-glycolipid derivatives, their preparation and use as adjuvants in vaccines, as being suitable for being co-administered with antigens for vaccine prophylaxis and therapy. In certain embodiments, the beta-glycol-lipid derivatives of the invention also in their salified or complex form, are suitable for being co-administered with antigens for both therapeutic and prophylactic purposes or for vaccine prophylaxis and therapy.
    Type: Application
    Filed: June 10, 2014
    Publication date: June 2, 2016
    Inventors: Angelo FONTANA, Emiliano MANZO, Adele CUTIGNANO, Raffaele DE PALMA
  • PROCESS FOR THE SEQUESTRATION OF CARBON DIOXIDE AND THE FERMENTATIVE PRODUCTION OF ORGANIC COMPOUNDS
    Publication number: 20150368680
    Abstract: A process is described for the use of biological components of anaerobic microorganisms, in particular cultures or enzymes of anaerobic bacteria from the order Thermotogales such as Thermotoga neapolitana, as agents for the capture and sequestration of carbon dioxide by reaction with an appropriate organic substrate. The products resulting from this reaction are organic molecules usable as raw materials in industries, such as food, biomedical, cosmetics and zootechnical industries.
    Type: Application
    Filed: January 24, 2014
    Publication date: December 24, 2015
    Inventors: Angelo FONTANA, Giuliana D'IPPOLITO, Laura DIPASQUALE